ITM-14D

N/A

Report date: 2025/11/25 15:52:41

Base Information

Drug NameITM-14D

Drug Alias NameITM-14D

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Nuclides > Gallium > 68Ga

Mechanisms of ActionSomatostatin receptor modulators

TargetsSomatostatin receptor

Therapy Area/IndicationsPancreatic neuroendocrine tumors (pNET)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesITM Radiopharmazie Munchen GmbH

China Registration ClassN/A

Develop Information

Active CompaniesITM Radiopharmazie Munchen GmbH

Inactive CompaniesN/A

Active IndicationsPancreatic neuroendocrine tumors (pNET)

Inactive IndicationsN/A

Other Information

ATC CodeN/A